Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 02021R0620-20230930

    Consolidated text: Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)Text with EEA relevance

    ELI: http://data.europa.eu/eli/reg_impl/2021/620/2023-09-30

    02021R0620 — EN — 30.09.2023 — 007.001


    This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

    ►B

    COMMISSION IMPLEMENTING REGULATION (EU) 2021/620

    of 15 April 2021

    laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases

    (Text with EEA relevance)

    (OJ L 131 16.4.2021, p. 78)

    Amended by:

     

     

    Official Journal

      No

    page

    date

    ►M1

    COMMISSION IMPLEMENTING REGULATION (EU) 2021/1008 of 21 June 2021

      L 222

    12

    22.6.2021

    ►M2

    COMMISSION IMPLEMENTING REGULATION (EU) 2021/1911 of 27 October 2021

      L 389

    2

    4.11.2021

    ►M3

    COMMISSION IMPLEMENTING REGULATION (EU) 2022/214 of 17 February 2022

      L 37

    16

    18.2.2022

    ►M4

    COMMISSION IMPLEMENTING REGULATION (EU) 2022/1218 of 14 July 2022

      L 188

    65

    15.7.2022

    ►M5

    COMMISSION IMPLEMENTING REGULATION (EU) 2023/150 of 20 January 2023

      L 20

    33

    23.1.2023

    ►M6

    COMMISSION IMPLEMENTING REGULATIONZ (EU) 2023/1071 of 1 June 2023

      L 143

    105

    2.6.2023

    ►M7

    COMMISSION IMPLEMENTING REGULATION (EU) 2023/2057 of 26 September 2023

      L 238

    94

    27.9.2023




    ▼B

    COMMISSION IMPLEMENTING REGULATION (EU) 2021/620

    of 15 April 2021

    laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases

    (Text with EEA relevance)



    Article 1

    Subject matter and scope

    1.  
    This Regulation lays down implementing rules for the listed diseases referred to in Article 9(1)(a), (b) and (c) of Regulation (EU) 2016/429 of animals, as regards the disease-free and non-vaccination status of certain Member States ( 1 ) or zones or compartments thereof, and the approval of eradication programmes for those listed diseases.
    2.  
    The Annexes to this Regulation list both the Member States or zones or compartments thereof whose disease-free status or eradication programmes shall be deemed to be approved as provided for in Article 280 of Regulation (EU) 2016/429, and those whose disease-free status and eradication programmes shall be duly approved by this Regulation and also duly listed in the Annexes thereto.
    3.  

    This Regulation lists in the Annexes thereto:

    (a) 

    the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.

    (b) 

    the Member States or zones thereof with approved disease-free status and non-vaccination status;

    (c) 

    the compartments of Member States with recognised disease-free status.

    Article 2

    Infection with Brucella abortus, B. melitensis and B. suis

    1.  
    The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part I of Annex I.
    2.  
    The Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part I of Annex I.

    ▼M3

    3.  
    The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations shall be listed in Chapter 1 of Part II of Annex I.
    4.  
    The Member States or zones thereof with an approved compulsory eradication programme for infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations shall be listed in Chapter 2 of Part II of Annex I.

    ▼B

    Article 3

    Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) (MTBC)

    1.  
    The Member States or zones thereof with disease-free status from infection with Mycobacterium tuberculosis complex (Mycobacterium bovis, M.caprae and M. tuberculosis) (MTBC) shall be listed in Part I of Annex II.
    2.  
    The Member States or zones thereof with an approved compulsory eradication programme for infection with MTBC shall be listed in Part II of Annex II.

    Article 4

    Infection with rabies virus (RABV)

    1.  
    The Member States or zones thereof with disease-free status from infection with rabies virus (RABV) shall be listed in Part I of Annex III.
    2.  
    The Member States or zones thereof with an approved compulsory eradication programme for infection with RABV shall be listed in Part II of Annex III.

    Article 5

    Enzootic bovine leukosis (EBL)

    1.  
    The Member States or zones thereof with disease-free status from enzootic bovine leukosis (EBL) shall be listed in Part I of Annex IV.
    2.  
    The Member States or zones thereof with an approved optional eradication programme for EBL shall be listed in Part II of Annex IV.

    Article 6

    Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)

    1.  
    The Member States or zones thereof with disease-free status from infectious bovine rinotracheitis/infectious pustular vulvovaginitis (IBR/IPV) shall be listed in Part I of Annex V.
    2.  
    The Member States or zones thereof with an approved optional eradication programme for IBR/IPV shall be listed in Part II of Annex V.

    Article 7

    Infection with Aujeszky’s disease virus(ADV)

    1.  
    The Member States or zones thereof with disease-free status from infection with Aujeszky’s disease virus (ADV) shall be listed in Part I of Annex VI.
    2.  
    The Member States or zones thereof with an approved optional eradication programme for infection with ADV shall be listed in Part II of Annex VI.

    Article 8

    Bovine viral diarrhoea (BVD)

    1.  
    The Member States or zones thereof with disease-free status from Bovine viral diarroea (BVD) shall be listed in Part I of Annex VII.
    2.  
    The Member States or zones thereof with an approved optional eradication programme for infection with BVD shall be listed in Part II of Annex VII.

    Article 9

    Infection with bluetongue virus (serotypes 1-24) (infection with BTV)

    1.  
    The Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) shall be listed in Part I of Annex VIII.
    2.  
    The Member States or zones thereof with an approved optional eradication programme for infection with BTV shall be listed in Part II of Annex VIII.

    Article 10

    Infestation with Varroa spp.

    The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.

    Article 11

    Infection with Newcastle disease virus

    The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.

    Article 12

    Infection with highly pathogenic avian influenza (HPAI)

    Compartments of the Member States free from HPAI shall be listed in Annex XI.

    Article 13

    Viral haemorrhagic septicaemia (VHS)

    1.  

    The following shall be listed in Part I of Annex XII:

    (a) 

    Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

    (c) 

    zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XII:

    (a) 

    Member States where their whole territory has an approved eradication programme for VHS;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 14

    Infectious haematopoietic necrosis (IHN)

    1.  

    The following shall be listed in Part I of Annex XIII:

    (a) 

    Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and

    (c) 

    zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XIII:

    (a) 

    Member States where their whole territory has an approved eradication programme for IHN;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 15

    Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)

    1.  

    The following shall be listed in Part I of Annex XIV:

    (a) 

    Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

    (c) 

    zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XIV:

    (a) 

    Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 16

    Infection with Marteilia refringens

    1.  

    The following shall be listed in Part I of Annex XV:

    (a) 

    Member States where their whole territory has disease-free status from infection with Marteilia refringens;

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

    (c) 

    zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XV:

    (a) 

    Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 17

    Infection with Bonamia exitiosa

    1.  

    The following shall be listed in Part I of Annex XVI:

    (a) 

    Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

    (c) 

    zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XVI:

    (a) 

    Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 18

    Infection with Bonamia ostreae

    1.  

    The following shall be listed in Part I of Annex XVII:

    (a) 

    Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

    (c) 

    zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XVII:

    (a) 

    Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 19

    Infection with white spot syndrome virus (WSSV)

    1.  

    The following shall be listed in Part I of Annex XVIII:

    (a) 

    Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);

    (b) 

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

    (c) 

    zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    2.  

    The following shall be listed in Part II of Annex XVIII:

    (a) 

    Member States where their whole territory has an approved eradication programme for infection with WSSV;

    (b) 

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

    (c) 

    zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.

    Article 20

    Repeal

    The following acts are repealed:

    — 
    Decision 93/52/EEC,
    — 
    Decision 94/963/EC,
    — 
    Decision 95/98/EC,
    — 
    Decision 2003/467/EC,
    — 
    Decision 2004/558/EC,
    — 
    Decision 2008/185/EC,
    — 
    Decision 2009/177/EC,
    — 
    Regulation (EC) No 616/2009,
    — 
    Implementing Decision 2013/503/EU.

    Article 21

    Entry into force and application

    This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

    It shall apply from 21 April 2021.

    This Regulation shall be binding in its entirety and directly applicable in all Member States.




    ANNEX I

    INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS

    PART I

    Disease-free status from infection with Brucella abortus, B. melitensis and B. suis

    CHAPTER 1

    Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    ▼M3

    Spain

    Whole territory

    ▼B

    France

    Whole territory

    ▼M1

    Croatia

    Whole territory

    ▼M6

    Italy

    Regione Abruzzo: Provincia di Pescara, Teramo

    Regione Basilicata: Provincia di Matera

    Regione Calabria: Provincia di Vibo Valentia

    Regione Campania: Provincia di Avellino, Benevento, Napoli

    Regione Emilia-Romagna

    Regione Friuli Venezia Giulia

    Regione Lazio

    Regione Liguria

    Regione Lombardia

    Regione Marche

    Regione Molise: Provincia di Campobasso

    Regione Piemonte

    Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce

    Regione Sardegna

    Regione Toscana

    Regione Trentino – Alto Adige

    Regione Umbria

    Regione Valle d’Aosta

    Regione Veneto

    ▼B

    Cyprus

    Whole territory

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    Malta

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    ▼M6

    Portugal

    Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu

    Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira

    ▼B

    Romania

    Whole territory

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼M4

    CHAPTER 2

    Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    Spain

    Whole territory

    ▼M6

    France

    Whole territory

    Italy

    Regione Abruzzo

    Regione Calabria: Province di Catanzaro, Cosenza

    Regione Campania: Provincia di Benevento, Napoli, Salerno

    Regione Emilia-Romagna

    Regione Friuli Venezia Giulia

    Regione Lazio

    Regione Liguria

    Regione Lombardia

    Regione Marche

    Regione Molise

    Regione Piemonte

    Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto

    Regione Sardegna

    Regione Toscana

    Regione Trentino – Alto Adige

    Regione Umbria

    Regione Valle d’Aosta

    Regione Veneto

    ▼M4

    Cyprus

    Whole territory

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    Hungary

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    Portugal

    Região Autónoma dos Açores

    Romania

    Whole territory

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼M3

    PART II

    Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis

    CHAPTER 1

    Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations



    Member State

    Territory

    Bulgaria

    Whole territory

    Greece

    Whole territory

    Hungary

    Whole territory

    ▼M6

    Italy

    Regione Abruzzo: Provincia dell’Aquila, di Chieti

    Regione Basilicata: Provincia di Potenza

    Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria

    Regione Campania: Provincia di Caserta, Salerno

    Regione Molise: Provincia di Isernia

    Regione Puglia: Provincia di Foggia, Taranto

    Regione Sicilia

    Portugal

    Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real

    Região Autónoma da Madeira

    Região Autónoma dos Açores: Ilha de São Miguel

    ▼M3

    CHAPTER 2

    Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations



    Member State

    Territory

    Bulgaria

    Whole territor

    Croatia

    Whole territory

    Greece

    Whole territory

    ▼M6

    Italy

    Regione Basilicata

    Regione Calabria: Provincia di Crotone, Reggio Calabria, Vibo Valentia

    Regione Campania: Provincia di Caserta, Avellino

    Regione Puglia: Provincia di Foggia

    Regione Sicilia

    ▼M3

    Portugal

    Região Madeira

    Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu

    ▼B




    ANNEX II

    INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)

    ▼M4

    PART I

    Member States or zones thereof with disease-free status from infection with MTBC



    Member State

    Territory

    Belgium

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    ▼M6

    Spain

    Comunidad Autónoma de Canarias

    Comunidad Autónoma de Castilla y León: Province of Burgos, León, Valladolid

    Comunidad Autónoma de Cataluña

    Comunidad Autónoma de Galicia

    Comunidad Autónoma de Islas Baleares

    Comunidad Autónoma de Murcia

    Comunidad Autónoma del País Vasco

    Comunidad Autónoma del Principado de Asturias

    ▼M4

    France

    Whole territory

    ▼M6

    Italy

    Regione Abruzzo

    Regione Basilicata: Provincia di Matera

    Regione Calabria: Provincia di Catanzaro

    Regione Campania: Provincia di Napoli

    Regione Emilia-Romagna

    Regione Friuli Venezia Giulia

    Regione Lazio: Provincia di Frosinone, Latina, Rieti, Viterbo

    Regione Liguria

    Regione Lombardia

    Regione Marche: Provincia di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino

    Regione Molise

    Regione Piemonte

    Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto

    Regione Sardegna: Città metropolitana di Cagliari, Provincia di Medio Campidano, Nord Est Sardegna, Nuoro, Ogliastra, Oristano, Sulcis Iglesiente

    Regione Toscana

    Regione Trentino – Alto Adige

    Regione Umbria

    Regione Valle d’Aosta

    Regione Veneto

    ▼M4

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    Hungary

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    Portugal

    Região Algarve: all distritos

    Região Autónoma dos Açores except Ilha de São Miguel

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    PART II

    Member States or zones thereof with an approved eradication programme for infection with MTBC



    Member State (*1)

    Territory

    Bulgaria

    Whole territory

    Croatia

    Whole territory

    Cyprus

    Whole territory

    Greece

    Whole territory

    Ireland

    Whole territory

    ▼M6

    Italy

    Regione Basilicata: Provincia di Potenza

    Regione Calabria: Provincia di Cosenza, Crotone, Reggio Calabria, Vibo Valentia

    Regione Campania: Provincia d’Avellino, Caserta, Benevento, Salerno

    Regione Lazio: Provincia di Roma

    Regione Marche: Provincia di Macerata

    Regione Puglia: Provincia di Foggia

    Regione Sardegna: Città metropolitana di Sassari

    Regione Sicilia

    ▼M4

    Malta

    Whole territory

    Portugal

    Região Autónoma dos Açores: Ilha de São Miguel

    Região Autónoma da Madeira

    Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu

    Romania

    Whole territory

    ▼M6

    Spain

    Comunidad Autónoma de Andalucía

    Comunidad Autónoma de Aragón

    Comunidad Autónoma de Cantabria

    Comunidad Autónoma de Castilla-La Mancha

    Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora

    Comunidad Autónoma de Extremadura

    Comunidad Autónoma de La Rioja

    Comunidad Autónoma de Madrid

    Comunidad Autónoma de Navarra

    Comunidad Autónoma de Valencia

    ▼M4

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼B




    ANNEX III

    INFECTION WITH THE RABIES VIRUS (RABV)

    PART I

    Member States or zones thereof with disease-free status from infection with RABV



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Bulgaria

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    Greece

    Whole territory

    ▼M3

    Spain

    Whole territory

    France

    Whole territory

    ▼B

    Croatia

    Whole territory

    Italy

    Whole territory

    Cyprus

    Whole territory

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    ▼M5

    Hungary

    Whole territory except Szabolcs-Szatmár-Bereg megye

    ▼B

    Malta

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    ▼M3

    Poland

    Voivodship Dolnośląskie: all powiaty

    Voivodship Kujawsko-pomorskie: all powiaty

    Voivodship Lubelskie the following powiaty: m. Lublin, Łęczyński, Parczewski, Radzyński, Świdnicki

    Voivodship Lubuskie: all powiaty

    Voivodship Łódzkie the following powiaty: Bełchatowski, Brzeziński, Kutnowski, Łaski, Łęczycki, Łowicki, Łódzki Wschodni, m. Łódź, Pabianicki, Pajęczański, Piotrkowski, m. Piotrków Trybunalski, Poddębicki, Radomszczański, Rawski, Sieradzki, Skierniewicki, m. Skierniewice, Tomaszowski, Wieluński, Wieruszowski, Zduńskowolski, Zgierski

    Voivodship Małopolskie: all powiaty

    Voivodship Mazowieckie the following powiaty: Ciechanowski, Gostyniński, Makowski, Mławski, Ostrołęcki, m. Ostrołęka, Płocki, m. Płock, Przasnyski, Sierpecki, Żuromiński

    Voivodship Opolskie: all powiaty

    Voivodship Podlaskie: all powiaty

    Voivodship Pomorskie: all powiaty

    Voivodship Śląskie: all powiaty

    Voivodship Świętokrzyskie the following powiaty: Buski, Kazimierski, Pińczowski, Włoszczowski

    Voivodship Warmińsko-mazurskie: all powiaty

    Voivodship Wielkopolskie: all powiaty

    Voivodship Zachodniopomorskie: all powiaty

    ▼B

    Portugal

    Whole territory

    Slovenia

    Whole territory

    ▼M6

    Slovakia

    Whole territory, except the following regions:

    Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský

    Michalovce, Sobrance, Trebišov in kraj Košický

    ▼B

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼M3

    PART II

    Member States or zones thereof with an approved eradication programme for infection with RABV



    Member State

    Territory

    ▼M5

    Hungary

    Szabolcs-Szatmár-Bereg megye

    ▼M3

    Poland

    Voivodship Lubelskie the following powiaty: Bialski, m. Biała Podlaska, Biłgorajski, Chełmski, m. Chełm, Hrubieszowski, Janowski, Krasnostawski, Kraśnicki, Lubartowski, Lubelski, Łukowski, Opolski, Puławski, Rycki, Tomaszowski, Włodawski, Zamojski, m. Zamość

    Voivodship Łódzkie the following powiaty: Opoczyński

    Voivodship Mazowieckie the following powiaty: Białobrzeski, Garwoliński, Grodziski, Grójecki, Kozienicki, Legionowski, Lipski, Łosicki, Miński, Nowodworski, Ostrowski, Otwocki, Piaseczyński, Płoński, Pruszkowski, Przysuski, Pułtuski, Radomski, m. Radom, Siedlecki, m. Siedlce, Sochaczewski, Sokołowski, Szydłowiecki, m.st. Warszawa, Warszawski Zachodni, Węgrowski, Wołomiński, Wyszkowski, Zwoleński, Żyrardowski

    Voivodship Podkarpackie

    Voivodship Świętokrzyskie the following powiaty: Jędrzejowski, Kielecki, m. Kielce, Konecki, Opatowski, Ostrowiecki, Sandomierski, Skarżyski, Starachowicki, Staszowski

    Romania

    Whole territory

    ▼M6

    Slovakia

    Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský

    Region Michalovce, Sobrance, Trebišov in kraj Košický

    ▼B




    ANNEX IV

    ENZOOTIC BOVINE LEUKOSIS (EBL)

    PART I

    Member States or zones thereof with disease-free status from EBL



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    Spain

    Whole territory

    France

    Région Auvergne et Rhône-Alpes

    Région Bourgogne-Franche-Comté

    Région Bretagne

    Région Centre-Val de Loire

    Région Corse

    Région Grande Est

    Région Hauts-de-France

    Région Ile-de-France

    Région Normandie

    Région Nouvelle-Aquitaine

    Région Occitanie

    Région Pays de la Loire

    Région Provence-Alpes-Côte d’Azur

    Région Guadeloupe

    Région Guyane

    Région Martinique

    Région Mayotte

    Italy

    Whole territory

    Cyprus

    Whole territory

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    ▼M6

    Portugal

    Whole territory, except Região Autónoma da Madeira

    ▼B

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼M4

    PART II

    Member States or zones thereof with an approved eradication programme for EBL



    Member State

    Territory

    Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

    Croatia

    Whole territory

    18 July 2022

    ▼B




    ANNEX V

    INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)

    PART I

    Member States or zones thereof with disease-free status from IBR/IPV



    Member State

    Territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Italy

    Regione Valle d’Aosta

    Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige

    Austria

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    PART II

    Member States or zones thereof with an approved eradication programme for IBR/IPV



    Member State

    Territory

    Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689

    Belgium

    Whole territory

    21 April 2021

    France

    Région Auvergne et Rhône-Alpes

    Région Bourgogne-Franche-Comté

    Région Bretagne

    Région Centre-Val de Loire

    Région Grande Est

    Région Hauts-de-France

    Région Ile-de-France

    Région Normandie

    Région Nouvelle-Aquitaine

    Région Occitanie

    Région Pays de la Loire

    Région Provence-Alpes-Côte d’Azur

    21 April 2021

    Italy

    Region Friuli Venezia Giulia

    Regione Trentino – Alto Adige: Provincia Autonoma di Trento

    21 April 2021

    Luxembourg

    Whole territory

    21 April 2021

    ▼M6

    Slovakia

    Kraj Bratislava

    Kraj Košice

    Kraj Prešov

    Kraj Trnava

    Kraj Žilina

    5 June 2023

    ▼B




    ANNEX VI

    AUJESZKY’S DISEASE VIRUS (ADV)

    PART I

    Member States or zones thereof with disease-free status from infection with ADV



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    France

    The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines

    ▼M5

    Italy

    Regione Friuli Venezia Giulia

    Regione Trentino – Alto Adige

    Regione Veneto

    ▼B

    Cyprus

    Whole territory

    Luxembourg

    Whole territory

    Hungary

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    ▼M6

    Poland

    Whole territory

    ▼B

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States or zones thereof with an approved eradication programme for infection with ADV



    Member State

    Territory

    Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689

    Spain

    Whole territory

    21 April 2021

    ▼M5

    Italy

    Regione Abruzzo

    Regione Apulia

    Regione Basilicata

    Regione Calabria

    Regione Campania

    Regione Emilia-Romagna

    Regione Lazio

    Regione Liguria

    Regione Lombardia

    Regione Marche

    Regione Molise

    Regione Piemonte

    Regione Sicilia

    Regione Toscana

    Regione Valle d’Aosta

    Regione Umbria

    21 April 2021

    ▼B

    Lithuania

    Whole territory

    21 April 2021

    ▼M6 —————

    ▼B

    Portugal

    Whole peninsular territory

    21 April 2021




    ANNEX VII

    BOVINE VIRAL DIARRHOEA (BVD)

    ▼M4

    PART I

    Member States or zones thereof with disease-free status from BVD



    Member State

    Territory

    Austria

    Whole territory

    Denmark

    Whole territory

    Finland

    Whole territory

    ▼M7

    Germany

    Bundesland Baden-Württemberg

    Bundesland Bayern

    Bundesland Brandenburg

    Bundesland Bremen

    Bundesland Hamburg

    Bundesland Hessen

    Bundesland Mecklenburg-Vorpommern

    Bundesland Niedersachsen, except Landkreis Cuxhaven, Göttingen, Northeim, Oldenburg, Stade

    Bundesland Nordrhein-Westfalen, except Kreis Borken, Gütersloh, Höxter, Kleve, Paderborn

    Bundesland Schleswig-Holstein, except Kreis Rendsburg-Eckernförde

    Bundesland Rheinland-Pfalz

    Bundesland Saarland

    Bundesland Sachsen

    Bundesland Sachsen-Anhalt

    Bundesland Thüringen

    ▼M4

    Sweden

    Whole territory

    PART II

    Member States or zones thereof with an approved eradication programme for BVD



    Member State

    Territory

    Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

    ▼M7

    Germany

    Bundesland Berlin

    Bundesland Niedersachsen:

    Landkreis Cuxhaven, Göttingen, Northeim, Oldenburg, Stade

    Bundesland Nordrhein-Westfalen:

    Kreis Borken, Gütersloh, Höxter, Kleve, Paderborn

    Bundesland Schleswig-Holstein:

    Kreis Rendsburg-Eckernförde

    21 February 2022

    ▼M4

    Ireland

    Whole territory

    18 July 2022

    ▼B




    ANNEX VIII

    INFECTION WITH BLUETONGUE VIRUS (BTV)

    PART I

    Member States or zones thereof with disease-free status from infection with BTV



    Member State (*1)

    Territory

    ▼M6

    Belgium

    Whole territory

    ▼B

    Czechia

    Whole territory

    Denmark

    Whole territory

    ▼M6

    Germany

    Whole territory

    ▼B

    Estonia

    Whole territory

    Ireland

    Whole territory

    ▼M6

    Spain

    Comunidad Autónoma de Andalucía: Province of Almería

    Province of Granada, the following districts: Alhama de Granada (Alhama/Temple), Baza (Altiplanicie Sur), Guadix (Hoya-Altiplanicie de Guadix), Huescar (Altiplanicie Norte), Iznalloz (Montes Orientales), Loja (Vega/Montes Occ.), Orgiva (Alpujarra/Valle de Lecrin), Santa Fe (Vega de Granada)

    Comunidad Autónoma de Aragón

    Comunidad Autónoma de Asturias

    Comunidad Autónoma de Canarias Comunidad Autónoma de Cantabria

    Comunidad Autónoma de Castilla-La Mancha, except the following districts:

    Almadén, Almodóvar del Campo, Piedrabuena in the Province of Ciudad Real

    Belvis de la Jara, Gálvez, Los Navalmorales, Oropesa, Talavera de la Reina, Toledo, Torrijos in the Province of Toledo

    Comunidad Autónoma de Castilla y León, except the following areas:

    Province of Salamanca

    Ávila, Arenas de San Pedro, Candeleda, Cebrero, El Barco de Ávila, El Barraco, Navaluenga, Navarredonda de Gredos, Piedrahíta, San Pedro del Arroyo, Sotillo de la Adrada in the Province of Ávila

    Alcañices, Bermillo de Sayago, Puebla de Sanabria in the Province of Zamora

    Comunidad Autónoma de Cataluña

    Comunidad Autónoma de Galicia except the following areas:

    Province of Orense

    Province of Pontevedra

    Sarria, Chantada and Terra de Lemos-Quiroga in the Province of Lugo

    Comunidad Autónoma de La Rioja

    Comunidad Autónoma de Madrid, except the following districts:

    Navalcarnero, San Martín de Valdeiglesias

    Comunidad Autónoma de Murcia

    Comunidad Autónoma de Navarra

    Comunidad Autónoma de País Vasco

    Comunidad Autónoma de Valencia

    ▼M1

    Italy

    Provincia Autonoma di Bolzano – Alto Adige

    Regione Valle d’Aosta

    Regione Friuli Venezia Giulia

    ▼B

    Latvia

    Whole territory

    ▼M1

    Lithuania

    Whole territory

    ▼M7

    Luxembourg

    Whole territory

    ▼B

    Hungary

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    ▼M5

    Portugal

    Região Autónoma dos Açores

    Região Autónoma da Madeira

    ▼B

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    ▼M6

    PART II

    Member States or zones thereof with an approved eradication programme for infection with BTV



    Member State

    Territory

    Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689

    Spain

    Communidad Autónoma de Andalucía:

    Provinces of Cádiz, Córdoba, Huelva, Jáén, Málaga, Sevilla

    Province of Granada: Motril (Costa de Granada)

    Communidad Autónoma de Castilla-La Mancha:

    Province of Ciudad Real, the following districts: Almadén, Almodóvar del Campo and Piedrabuena

    Province of Toledo, the following districts: Belvis de la Jara, Gálvez, Los Navalmorales, Oropesa, Talavera de la Reina, Toledo, Torrijos

    Comunidad Autónoma de Castilla y León:

    Province of Salamanca

    Province of Ávila, the following districts: Ávila, Arenas de San Pedro, Candeleda, Cebrero, El Barco de Ávila, El Barraco, Navaluenga, Navarredonda de Gredos, Piedrahíta, San Pedro del Arroyo, Sotillo de la Adrada

    Province of Zamora, the following districts: Alcañices, Bermillo de Sayago Puebla de Sanabria

    Communidad Autónoma de Extremadura

    Communidad Autónoma de Galicia:

    Province of Orense

    Province of Pontevedra

    Sarria, Chantada and Terra de Lemos-Quiroga in the Province of Lugo

    Communidad Autónoma de Islas Baleares

    Comunidad Autónoma de Madrid, the following districts:

    Navalcarnero, San Martín de Valdeiglesias

    21 February 2022

    ▼B




    ANNEX IX

    INFESTATION WITH VARROA SPP.

    Member States or zones thereof with disease-free status from infestation with Varroa spp.



    Member State

    Territory

    Portugal

    Island of Corvo

    Island of Graciosa

    Island of São Jorge

    Island of Santa Maria

    Island of São Miguel

    Island of Terceira

    ▼M2

    Finland

    Åland Islands, except the municipality of Brändö

    ▼B




    ANNEX X

    INFECTION WITH NEWCASTLE DISEASE VIRUS

    Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination



    Member State

    Territory

    Finland

    Whole territory

    Sweden

    Whole territory




    ANNEX XI

    HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)

    Compartments free from HPAI



    Member State

    Name

    France

    Compartiment ISA Bretagne comprising the establishments with codes EDE 22080055, 22277180, 22203429, 22059174 and 22295000.

    Compartiment SASSO Sabres comprising the establishment with Code EDE 40246082.

    Compartiment SASSO Soulitré comprising the establishment with Code EDE 72341105.

    Netherlands

    Verbeek’s poultry international B.V with approval number 1122.

    Institut de selection animale B.V with approval number 2338.

    Cobb Europe B.V. with approval number 2951.




    ANNEX XII

    VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)

    PART I

    Member States whose whole territory has disease-free status from VHS;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and

    zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State (*1)

    Territory

    Denmark

    Whole continental territory

    Ireland

    Whole territory

    Cyprus

    Whole continental territory

    ▼M5

    Finland

    Whole territory

    ▼B

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States where their whole territory has an approved eradication programme for VHS;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;

    and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State

    Territory

    Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689

    Estonia

    Whole territory

    21 April 2021




    ANNEX XIII

    INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)

    PART I

    Member States where their whole territory has disease-free status from IHN;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;

    and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State (*1)

    Territory

    ▼M3 —————

    ▼B

    Ireland

    Whole territory

    Cyprus

    Whole continental territory

    ▼M5

    Finland

    Whole territory, except for the following:

    1)  the coastal compartment comprised of the parts of Föglö, Lumparland, Lemland, Vårdö municipalities that are contained within a circle of radius 19,331 km, centered on WGS84 coordinates Lat 59.975253701°, Lon 20.454027317°

    2)  the coastal compartment comprised of the parts of Eckerö and Hammarland municipalities that are contained within a circle of radius 10 km, centered on WGS84 coordinates Lat 60.207175390°, Lon 19.507907780°

    ▼B

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States where their whole territory has an approved eradication programme for IHN;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and

    zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State

    Territory

    Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689

    Estonia

    Whole territory

    21 April 2021




    ANNEX XIV

    INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)

    PART I

    Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and

    zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State (*1)

    Territory

    Belgium

    Whole territory

    Bulgaria

    Whole territory

    Czechia

    Whole territory

    Denmark

    Whole territory

    Germany

    Whole territory

    Estonia

    Whole territory

    Ireland

    Whole territory

    Greece

    Whole territory

    Spain

    Whole territory

    France

    Whole territory

    Croatia

    Whole territory

    Italy

    Whole territory

    Cyprus

    Whole territory

    Latvia

    Whole territory

    Lithuania

    Whole territory

    Luxembourg

    Whole territory

    Hungary

    Whole territory

    Malta

    Whole territory

    Netherlands

    Whole territory

    Austria

    Whole territory

    Poland

    Whole territory

    Portugal

    Whole territory

    Romania

    Whole territory

    Slovenia

    Whole territory

    Slovakia

    Whole territory

    Finland

    Whole territory

    Sweden

    Whole territory

    United Kingdom (Northern Ireland)

    Northern Ireland

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and

    zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.




    ANNEX XV

    INFECTION WITH MARTEILIA REFRINGENS

    PART I

    Member States where their whole territory has disease-free status from infection with Marteilia refringens;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and

    zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State (*1)

    Territory

    Ireland

    Whole territory

    United Kingdom (Northern Ireland)

    The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay.

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and

    zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.




    ANNEX XVI

    INFECTION WITH BONAMIA EXITIOSA

    PART I

    Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and

    zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State

    Territory

    Estonia

    Whole territory

    PART II

    Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and

    zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.




    ANNEX XVII

    INFECTION WITH BONAMIA OSTREAE

    PART I

    Member States where their whole territory has disease-free status from infection with Bonamia ostreae;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and

    zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country



    Member State (*1)

    Territory

    Estonia

    Whole territory

    Ireland

    The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay.

    United Kingdom (Northern Ireland)

    The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough.

    (*1)   

    In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    PART II

    Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and

    zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.




    ANNEX XVIII

    INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)

    PART I

    Member States where their whole territory has disease-free status from infection with WSSV;

    zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and

    zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.

    PART II

    Member States where their whole territory has an approved eradication programme for infection with WSSV;

    zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and

    zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country

    None at present.



    ( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Regulation references to Member States include the United Kingdom in respect of Northern Ireland.

    Top